Literature DB >> 3278880

Alopecia and hirsuties. Current concepts in pathogenesis and management.

J H Barth1.   

Abstract

Hirsuties and androgenic alopecia are the patterns of hair growth in women which develop in a similar manner to that normally seen in men. This process is mediated by androgens. It may be due to increased hormone production or increased target organ sensitivity. The majority of patients with hirsuties may be adequately managed with a careful explanation of their condition and advice about depilatory techniques. Some will benefit from a course of systemic antiandrogen therapy, but hair growth will resume on cessation of therapy. There have been few objective studies to evaluate the benefits of antiandrogen therapy in female baldness and none with minoxidil.

Entities:  

Mesh:

Year:  1988        PMID: 3278880     DOI: 10.2165/00003495-198835010-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  40 in total

1.  THE PREVALENCE OF "HIRSUTISM" IN YOUNG WOMEN.

Authors:  E MCKNIGHT
Journal:  Lancet       Date:  1964-02-22       Impact factor: 79.321

2.  Pathologic dynamics of human hair loss. I. Telogen effuvium.

Authors:  A M KLIGMAN
Journal:  Arch Dermatol       Date:  1961-02

3.  Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia.

Authors:  B M Burke; W J Cunliffe
Journal:  Br J Dermatol       Date:  1985-01       Impact factor: 9.302

4.  [Effect and side-effect of cyproteron-acetat-treatment (author's transl)].

Authors:  W Braendle; H Boess; M Breckwoldt; C Leven; G Bettendorf
Journal:  Arch Gynakol       Date:  1974-07-05

5.  Adrenal androgenic female-pattern alopecia: sex hormones and the balding woman.

Authors:  J M Kasick; W F Bergfeld; W D Steck; M K Gupta
Journal:  Cleve Clin Q       Date:  1983

6.  The effect of spironolactone on hirsutism and female androgen metabolism.

Authors:  P Dorrington-Ward; A C McCartney; S Holland; J Scully; G Carter; J Alaghband-Zadeh; P Wise
Journal:  Clin Endocrinol (Oxf)       Date:  1985-08       Impact factor: 3.478

7.  Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex.

Authors:  E Ludwig
Journal:  Br J Dermatol       Date:  1977-09       Impact factor: 9.302

8.  Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche.

Authors:  A W Lucky; R L Rosenfield; J McGuire; S Rudy; J Helke
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

9.  Androgen receptor in human skin cytosol.

Authors:  I Mowszowicz; M Riahi; F Wright; P Bouchard; F Kuttenn; P Mauvais-Jarvis
Journal:  J Clin Endocrinol Metab       Date:  1981-02       Impact factor: 5.958

10.  Acanthosis nigricans in obese women with hyperandrogenism. Characterization of an insulin-resistant state distinct from the type A and B syndromes.

Authors:  J S Flier; R C Eastman; K L Minaker; D Matteson; J W Rowe
Journal:  Diabetes       Date:  1985-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.